Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Wan‐Long Chuang et al.|Liver International|2016Cited by 221
Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen–Negative PatientsWen‐Juei Jeng, Yun‐Fan Liaw, Yi‐Cheng Chen et al.|Clinical Gastroenterology and Hepatology|2016Cited by 91